Carbon Nanotubes: a viable drug delivery platform for the treatment of cancer

Abstract

The development of new drug delivery platforms and specific vectorization processes for the treatment of diseases like cancer has become vitally important for the pharmaceutical industry. One of these new platforms are functionalized carbon nanotubes (f-CNTs), which are characterized by their high aspect ratio, high loading capacity, rich surface chemistry with functional groupsfor binding drugs and molecules. It has been demonstrated that functionalization processes of CNTs generate a marked decrease in toxicity, which makes them ideal candidates for clinical studies for their use as drug vectors.